| Sources | Names Used |
|---|---|
| CTRPv2 | PRL-3 inhibitor I |
| PharmacoGx | PRL-3 Inhibitor I |
| Database | Identifier |
|---|---|
| Smiles: | Brc1ccc(OCc2ccccc2Br)c(/C=C3/SC(=S)NC3=O)c1 |
| Pubchem: | 11983303 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CXCL2 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | PSMD13 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | TCP10 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | ZNF682 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | ADGRE5 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | C19orf68 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | SLC25A16 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | POMT2 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | CAPZA3 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | FASTKD1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.09 |
